Simon, Christopher 4
4 · HAEMONETICS CORP · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Simon, Christopher
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2024-06-06$87.38/sh−71,335$6,233,252→ 362,542 total - Exercise/Conversion
Common Stock
2024-06-06$41.64/sh+104,516$4,352,046→ 433,877 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2024-06-06−104,516→ 0 totalExercise: $41.64From: 2018-06-06Exp: 2024-06-06→ Common Stock (104,516 underlying)
Footnotes (4)
- [F1]Represents an automatic exercise of options granted in 2017 and scheduled to expire after June 6, 2024, as reflected in this Form 4.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.